FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387113007: Bacitracin ophthalmic preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461291014 Bacitracin ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481224018 Bacitracin ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bacitracin ophthalmic preparation Is a Bacitracin false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bacitracin-containing product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bacitracin ophthalmic preparation Inferred relationship Some
    Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bacitracin ophthalmic preparation Inferred relationship Some
    bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bacitracin ophthalmic preparation Inferred relationship Some
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bacitracin ophthalmic preparation Inferred relationship Some
    bacitracinzink 500 enheder + polymyxin B-sulfat 10.000 enheder salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bacitracin ophthalmic preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set (foundation metadata concept)

    Back to Start